[The inflammation-inhibiting effect of adrenal cortex  hormones, mucopolysaccharidepolysulfuric acid ester and salicylic acid after percutaneous administration].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004357:Drug Synergism; D004487:Edema / Q000188:drug therapy*; D006025:Glycosaminoglycans; D006099:Granuloma / Q000188:drug therapy*; D008297:Male; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats; D012459:Salicylates / Q000008:administration & dosage*; D013464:Sulfuric Acids
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D006025:Glycosaminoglycans; D012459:Salicylates; D013464:Sulfuric Acids
Die entzündungshemmende Wirkung von Nebennierenrindenhormonen, Mucopolysaccharidpolyschwefelsäureester und Salicylsäure nach percutaner Anwendung.